Unlock stock picks and a broker-level newsfeed that powers Wall Street.
3 Overlooked High-Yield Stocks Trading at a P/E of Less Than 10

In This Article:

Towards the end of 2021, Nvidia (NASDAQ:NVDA) stock was trading at $300. NVDA stock corrected to lows of $108 by October 2022 before skyrocketing by more than 200% for year-to-date. The point I want to make is that the rally in blue-chip stock can be stellar from oversold levels. It does not take time for the market to identify and close the valuation gap. While the markets have trended higher in the last few quarters, there are several blue-chip high-yield stocks that trade at a significant valuation gap.

While these stocks have robust fundamentals and cash flows, these trade at a forward price-earnings ratio of 10 or lower. In general, the outlook for the markets is positive and several stocks trade at stretched valuations. As markets look for value, these stocks will be in the limelight. I believe that it’s a good time to accumulate these high-yield stocks for healthy total returns in the next 12 to 24 months.

Let’s discuss the reasons to be bullish on these blue-chip stocks.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Rio Tinto (RIO)

the rio tinto (RIO) logo on a building during daylight
the rio tinto (RIO) logo on a building during daylight

Source: Rob Bayer / Shutterstock.com

Rio Tinto (NYSE:RIO) stock has traded sideways for the last 12 months. A breakout on the upside seems imminent for this 5.78% dividend yield stock. My view is underscored by the point that RIO stock trades at a forward price-earnings ratio of 7.7.

An important point to note is that even with some softness in commodity prices, Rio generated operating cash flow of $7 billion for the first half of 2023. This provides the company with high financial flexibility for dividend and capital investments.

Another key point is that the iron ore business is the cash cow for Rio Tinto. However, the company is investing in copper and lithium mines, among others. The objective is to diversify towards metals that are likely to benefit from the global energy transition. With the Jadar lithium project, the company expects to be the largest source of lithium supply to Europe for the next 15 years.

Pfizer (PFE)

Here's How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal
Here's How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal

Source: Manuel Esteban / Shutterstock.com

The decline for Pfizer (NYSE:PFE) stock has been unabated in the last few quarters. The market seems to have overreacted to growth concerns and PFE stock looks attractive at a forward price-earnings ratio of 10. Besides the valuation gap providing scope for upside, PFE stock offers an attractive dividend yield of 4.79%.

From a growth perspective, there are two points to note. First, Pfizer is investing in the launch of new molecular entities. With a deep pipeline of candidates and aggressive investment in research and development, the outlook is positive. Pfizer expects $20 billion in incremental revenue by 2030 from new molecular entities.